Mobidiag Announces Release of Amplidiag® Viral GE, a Multiplex PCR Test to Detect Gastrointestinal Viruses Directly from Stool Samples

This Week’s News in Review

This Week's News in Review! Medical Device News Magazine keeps our readers up-to-date on breaking industry news! Learn how Medical Device News Magazine can help...

New Research Shows Nearly Half of Elderly Suffer Decreased Mobility During Lockdown

In a survey of UK adults with parents over the age of 75, while over half (52%) of respondents remain worried about their parents catching Covid, 48 percent are concerned about parental loneliness, and 46 percent about their parents falling alone and not being able to get up or get help. This figure remained high even among those whose parents are in care homes, with 37% of respondents still most concerned about parents falling over.

American College of Cardiology Names Ravee Kurian COO/CFO

Kurian comes to ACC following a 20-year stint at Publicis Sapient, a leading technology and communications consultancy, where he led critical and sensitive digital transformation initiatives for Fortune 500 and U.S. federal clients.

Mobidiag Ltd, a Finnish molecular diagnostics company, today announced the CE-IVD marking of Amplidiag® Viral GE, a molecular test allowing simultaneous detection of the main enteric viruses causing diarrhea. The available panel includes norovirus GI, norovirus GII, rotavirus, sapovirus, astrovirus, adenovirus 40 and 41.

Tuomas Tenkanen, CEO at Mobidiag: “Amplidiag Viral GE is a qualitative multiplex PCR test allowing cost-effective and fast analysis of the most common gastrointestinal viruses directly from stool samples by reducing substantially time to process samples and hands-on-time. By obtaining the CE-IVD marking, Amplidiag Viral GE adds up to the Amplidag product line, further expanding Mobidiag’s gastrointestinal test panels and making it one of the most comprehensive offers on the market.”

Amplidiag Viral GE test is now available directly through Mobidiag and local distributors.

spot_img

DON'T MISS

Dr Jonathan Slotkin Appointed to Peer Well Board of Directors

Alongside the appointment, PeerWell is launching its new clinical practice, PeerWell Health.

Zimmer Biomet Announces New Appointments to Executive Leadership Team

Wilfred van Zuilen Appointed as President of Europe, Middle East and Africa. Nitin Goyal, M.D. Appointed to Newly Created Role of Chief Science, Technology and Innovation Officer.

Subscribe to Medical Device News Magazine here.

Related Articles